National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI

Understanding Cancer Series: Blood Stem Cell Transplants
< Back to Main
In English En español
    Posted: 09/01/2006    Reviewed: 09/01/2006
Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
View/Print PDF  View/Print PDF
View/Print PowerPoint  View/Print PowerPoint
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Office of Biorepositories and Biospecimen Research

The Nation's Investment in Cancer Research FY 2010

Report to Nation Finds Declines in Cancer Incidence, Death Rates
Slide 2 : Blood Stem Cells previousnext

Blood stem cells, known as hematopoietic stem cells, reside primarily in marrow, the spongy interior of bones. These "starter" cells resupply three types of blood cells: erythrocytes, commonly known as red blood cells; platelets, also called the blood-clotting cells; and leukocytes, the white blood cells of the immune system.

When the body needs to replace red blood cells, platelets for blood clotting, or immune cells, stem cells located in the bone marrow mature in a process called hematopoiesis. Hematopoiesis goes on constantly in the human body, but certain conditions call for increased activity. For example, when a person moves to a high altitude or attempts to recover from serious bleeding, increased numbers of stem cells must move from the bone marrow into the bloodstream. 

Blood Stem Cells

< Previous  |  Index  |  Next Slide >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov